Blue Ocean Technologies

Blue Ocean Technologies is a Toronto-based biotech startup specializing in digital microfluidics (DMF) for rapid, point-of-care diagnostics. Founded in 2022 as a spinout from the University of Toronto, the company develops automated testing systems designed for high-stakes environments, such as emergency medicine and trauma care. By utilizing AI-driven detection algorithms and compact hardware, their platform aims to deliver lab-quality results in minutes using low-cost, disposable cartridges. The company’s capabilities were further strengthened by the acquisition of Sci-Bots, an expert in microfluidic hardware and the developer of the DropBot, an open-source digital microfluidic controller used globally by academic and industrial researchers.

The company addresses the critical need for fast, bedside diagnostics to reduce the burden on centralized healthcare infrastructure. Beyond their core diagnostic development, they provide R&D consulting and custom microfluidic system design for sectors including life sciences, agriculture, and industrial applications. By offering end-to-end support—from system design and prototyping to software integration—Blue Ocean Technologies helps partners overcome R&D limitations and transition complex microfluidic concepts into market-ready products. Their approach streamlines workflows, improves experimental reproducibility, and enables real-time decision-making in clinical and remote settings.